258 related articles for article (PubMed ID: 31190590)
1. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial.
Byrnes J; Ball J; Gao L; Kai Chan Y; Kularatna S; Stewart S; Scuffham PA
J Med Econ; 2019 Sep; 22(9):945-952. PubMed ID: 31190590
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
[TBL] [Abstract][Full Text] [Related]
3. Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study.
Maru S; Byrnes JM; Carrington MJ; Stewart S; Scuffham PA
J Med Econ; 2017 Apr; 20(4):318-327. PubMed ID: 27841726
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
5. Optimizing chronic disease management mega-analysis: economic evaluation.
Path-Theta Collaboration
Ont Health Technol Assess Ser; 2013; 13(13):1-148. PubMed ID: 24228076
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: The Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study.
Maru S; Byrnes J; Carrington MJ; Chan YK; Stewart S; Scuffham PA;
Eur J Cardiovasc Nurs; 2018 Jun; 17(5):439-445. PubMed ID: 29166769
[TBL] [Abstract][Full Text] [Related]
7. Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure.
Gao L; Moodie M
BMJ Open; 2019 Sep; 9(9):e031033. PubMed ID: 31492790
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.
Ademi Z; Pasupathi K; Liew D
Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
[TBL] [Abstract][Full Text] [Related]
10. Integrated Management Approach to Atrial Fibrillation Care: A Cost Utility Analysis.
Saraswat MK; Carter L; Berrigan P; Sapp JL; Gray C; Fearon A; Gardner M; Parkash R
Can J Cardiol; 2019 Sep; 35(9):1142-1148. PubMed ID: 31472812
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
[TBL] [Abstract][Full Text] [Related]
12. Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care - a multi-state survival model based on a randomized controlled trial.
Gao L; Scuffham P; Ball J; Stewart S; Byrnes J
J Med Econ; 2021; 24(1):87-95. PubMed ID: 33406944
[TBL] [Abstract][Full Text] [Related]
13. Costs and Cost-Utility of Critical Care and Subsequent Health Care: A Multicenter Prospective Study.
Jukarainen S; Mildh H; Pettilä V; Häkkinen U; Peltola M; Ala-Kokko T; Reinikainen M; Vaara ST
Crit Care Med; 2020 May; 48(5):e345-e355. PubMed ID: 31929342
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of ablation surgery in patients with atrial fibrillation undergoing cardiac surgery.
van Breugel NH; Bidar E; Essers BA; Nieman FH; Accord RE; Severens JL; Vrakking R; Maessen JG
Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):394-8. PubMed ID: 21148666
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a Home-Exercise Program Among Older People After Hospitalization.
Farag I; Howard K; Hayes AJ; Ferreira ML; Lord SR; Close JT; Vogler C; Dean CM; Cumming RG; Sherrington C
J Am Med Dir Assoc; 2015 Jun; 16(6):490-6. PubMed ID: 25703448
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).
Koek MB; Sigurdsson V; van Weelden H; Steegmans PH; Bruijnzeel-Koomen CA; Buskens E
BMJ; 2010 Apr; 340():c1490. PubMed ID: 20406865
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands.
Bennaghmouch N; de Veer AJWM; Mahmoodi BK; Jofre-Bonet M; Lip GYH; Bode K; Ten Berg JM
Eur Heart J Qual Care Clin Outcomes; 2019 Apr; 5(2):127-135. PubMed ID: 30016398
[TBL] [Abstract][Full Text] [Related]
18. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.
Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM
Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation.
Baykaner T; Duff S; Hasegawa JT; Mafilios MS; Turakhia MP
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):526-536. PubMed ID: 29436112
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
